CD248 as a novel therapeutic target in pulmonary arterial hypertension

MLA

Xu, Tao, et al. “CD248 as a Novel Therapeutic Target in Pulmonary Arterial Hypertension.” Clinical and Translational Medicine, vol. 10, no. 5, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bafbde466e28ba1124c22b0a4e3c21dc&authtype=sso&custid=ns315887.

APA

Xu, T., Shao, L., Wang, A., Liang, R., Lin, Y., Wang, G., Zhao, Y., Hu, J., & Liu, S. (2020). CD248 as a novel therapeutic target in pulmonary arterial hypertension. Clinical and Translational Medicine, 10(5).

Chicago

Xu, Tao, Lei Shao, Aimei Wang, Rui Liang, Yuhan Lin, Guan Wang, Yan Zhao, Jing Hu, and Shuangyue Liu. 2020. “CD248 as a Novel Therapeutic Target in Pulmonary Arterial Hypertension.” Clinical and Translational Medicine 10 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bafbde466e28ba1124c22b0a4e3c21dc&authtype=sso&custid=ns315887.